Skip to Content

BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion

Licence status
Authorised: 23/11/2015
Active substances
Blinatumomab
Dosage Form
Powder for concentrate and solution for solution for infusion
Licence number
EU/1/15/1047/001
Licence holder
Amgen Europe B.V.,

Licence information

ATC code
L01XC19 ZZZ Blinatumomab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
23/11/2015